Enhancing remyelination with CRISPR/Cas9 edited human oligodendrocyte precursor cells

被引：0
|
作者：
Wagstaff, L. J. [1 ,2 ]
Fidanza, A. [1 ,2 ]
Franklin, R. J. M. [3 ]
Williams, A. C. [1 ,2 ]
机构：
[1] Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland
[2] Univ Edinburgh, MS Soc Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[3] Univ Cambridge, Cambridge Stem Cell Inst, Wellcome Trust, MRC, Cambridge, England
来源：
GLIA | 2019年 / 67卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T16-020B
引用
收藏
页码：E666 / E666
页数：1
相关论文
共 50 条
  • [31] Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System
    Wang, Ling
    Yang, Likai
    Guo, Yijie
    Du, Weili
    Yin, Yajun
    Zhang, Tao
    Lu, Hongzhao
    PLOS ONE, 2017, 12 (01):
  • [32] Characterization of post-edited cells modified in the TFAM gene by CRISPR/Cas9 technology in the bovine model
    de Oliveira, Vanessa Cristina
    Mariano Junior, Clesio Gomes
    Belizario, Jose Ernesto
    Krieger, Jose Eduardo
    Bressan, Fabiana Fernandes
    Santos Roballo, Kelly Cristine
    Fantinato-Neto, Paulo
    Meirelles, Flavio Vieira
    Chiaratti, Marcos Roberto
    Concordet, Jean-Paul
    Ambrosio, Carlos Eduardo
    PLOS ONE, 2020, 15 (07):
  • [33] CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma
    Guo, Yelei
    Tong, Chuan
    Su, Liping
    Zhang, Wenying
    Jia, Hejin
    Liu, Yang
    Yang, Qingming
    Wu, Zhiqiang
    Wang, Yao
    Han, Weidong
    BLOOD ADVANCES, 2022, 6 (08) : 2695 - 2699
  • [34] Toward a CRISPR Picture: Use of CRISPR/Cas9 to Model Diseases in Human Stem Cells In Vitro
    Freiermuth, Jamie L.
    Powell-Castilla, Ian J.
    Gallicano, G. Ian
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) : 62 - 68
  • [35] Establishing cGMP Manufacturing of CRISPR/Cas9-Edited Human CAR T Cells
    Wang, Xiuyan
    Zabierowski, Susan E.
    Wu, Meilan
    Zhu, Mingzhu
    Del Casale, Christina
    Eyquem, Justin Eyquem
    Mansilla-Soto, Jorge
    Sadelain, Michel
    Riviere, Isabelle
    MOLECULAR THERAPY, 2020, 28 (04) : 66 - 67
  • [36] Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Wang, X.
    Zabierowski, S.
    Wu, M.
    Del Casale, C.
    Eyquem, J.
    Mansilla-Soto, J.
    Riviere, I.
    Sadelain, M.
    CYTOTHERAPY, 2020, 22 (05) : S138 - S139
  • [37] Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
    Zhang, Song
    Shen, Jiangtao
    Li, Dali
    Cheng, Yiyun
    THERANOSTICS, 2021, 11 (02): : 614 - 648
  • [38] Establishing cGMP Manufacturing of CRISPR/Cas9-Edited Human CAR T Cells
    Zabierowski, Susan
    Eyquem, Justin
    Mansilla-Soto, Jorge
    Feucht, Judith
    Wang, Xiuyan
    Riviere, Isabelle
    Sadelain, Michel
    MOLECULAR THERAPY, 2019, 27 (04) : 41 - 42
  • [39] Gene-ectomy: Gene Ablation with CRISPR/Cas9 in Human Hematopoietic Cells
    Calero-Garcia, Miguel
    Gaspar, H. Bobby
    CELL STEM CELL, 2014, 15 (05) : 529 - 530
  • [40] Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells
    Zheng, Qiupeng
    Cai, Xiaohong
    Tan, Meng How
    Schaffert, Steven
    Arnold, Christopher P.
    Gong, Xue
    Chen, Chang-Zheng
    Huang, Shenglin
    BIOTECHNIQUES, 2017, 62 (01) : xxii
12345